eMERGE is a national network organized and funded by the National Human Genome Research Institute (NHGRI) that combines DNA biorepositories with electronic medical record (EMR) systems for large scale, high-throughput genetic research in support of implementing genomic medicine.
Many factors contribute to risk of a disease. Some of these factors are internal, like genetics, and others are external, like where someone lives. Over the last several years researchers have discovered that in addition to one gene being associated with a given disease (monogenic factors), many genes across your genome can contribute to the development of a disease (polygenic factors). To learn more about elements that contribute to risk a disease, click here.
NIH Office of Data Science Strategy Releases Four Notices of Special Interest that Address Workforce/Strategic Gaps in Artificial Intelligence/Machine Learning
April 4, 2021 8:57 PM
Invitae to partner with eMERGE as a clinical affiliate to investigate monogenic risk of conditions
April 4, 2021 4:58 PM
Dr. Lori Orlando 2021 PROSE Award Recognition
March 3, 2021 1:11 PM
Lessons Learned from eMERGE III
January 1, 2021 3:53 PM
NHGRI announces the next round of the eMERGE Network
July 7, 2020 2:19 PM
Publication Update: MCS NT304 published in the American Journal of Human Genetics
May 5, 2020 1:09 PM
Beck AT, Sutton EJ, Chow CPY, Curtis SH, Sharp RR. "Who Doesn't Like Receiving Good News?" Perspectives of Individuals Who Received Genomic Screening Results by Mail. Journal of personalized medicine. 2021 Apr 21;11(5).
Saadatagah S, Jose M, Dikilitas O, Alhabi L, Kullo IJ. Genetic basis of hypercholesterolemia in adults. NPJ genomic medicine. 2021 Apr 14;6(1):28.
Suri P, Stanaway IB, Zhang Y, Freidin MB, Lee MT, et al. Genome-wide association studies of low back pain and lumbar spinal disorders using electronic health record data identify a locus associated with lumbar spinal stenosis. Pain. 2021 Feb 4;.